Target intelligence / Profile preview

Potassium voltage-gated channel subfamily A member 6 (KCNA6)

Target
KCNA6
Molecular classification
Ion channel, Voltage-gated potassium channel, Delayed rectifier potassium channel, Shaker-related potassium channel
01

Overview

Potassium voltage-gated channel subfamily A member 6 (KCNA6 or Kv1.6) is a delayed rectifier-type voltage-gated potassium channel alpha subunit belonging to the shaker-related family. The channel consists of four subunits, each with six transmembrane domains, and participates in the repolarization of the membrane potential in excitable cells such as neurons and muscle cells. KCNA6 contributes to the regulation of neurotransmitter release, heart rate, insulin secretion, and many other physiological processes. Its main mechanism involves forming a selective pore that permits potassium ions to exit the cell in response to membrane depolarization, thus restoring resting membrane potential. Recent studies have implicated de novo mutations in KCNA6 in neurodevelopmental disorders, including early-onset epilepsy and intellectual disability, due to dominant effects on channel deactivation. While there are no known highly selective drugs for Kv1.6, the target is considered significant for modulating excitability in the nervous and possibly endocrine systems.

Other names
Potassium voltage-gated channel subfamily A member 6KCNA6Kv1.6HBK2PPP1R96Voltage-gated potassium channel HBK2Voltage-gated potassium channel subunit Kv1.6protein phosphatase 1 regulatory subunit 96human brain potassium channel-2potassium channel, voltage-gated shaker-related subfamily A member 6potassium voltage-gated channel, shaker-related subfamily, member 6
02

Mechanism of action

For general potassium channel blockers: blockade of voltage-gated potassium channel pore, leading to prolonged action potentials. For activators: enhanced potassium efflux, increased membrane repolarization. For mutations: dominant-negative effects on deactivation kinetics, altered neuronal excitability.

03

Biological functions

Regulation of membrane potentialSignal transductionNeuronal excitabilitySynaptic transmissionRegulation of secretion (e.g., insulin)Control of heart rateSmooth muscle contractionEpithelial electrolyte transportCell volume regulation
04

Disease associations

Neurodevelopmental disorder (including epilepsy and intellectual disability)Possible associations: inverted nipples, farsightedness (hyperopia)Potential implication in conditions involving altered neuronal excitability (epilepsy, seizures)
05

Safety considerations

Non-selective blockade of voltage-gated potassium channels can cause cardiac arrhythmias, muscle weakness, and neurotoxicity because of the widespread roles of these channels in excitable tissues.Targeting Kv1.6 specifically may interfere with neuronal excitability, potentially resulting in seizures, neuropsychiatric symptoms, or other neurological adverse effects
06

Interacting drugs

4-aminopyridine

1 more in the full profile.

07

Biomarkers

Mutations in KCNA6 may serve as rare genetic biomarkers for certain neurodevelopmental disorders and epilepsiesNo clinically established approved biomarkers for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Potassium voltage-gated channel subfamily A member 6 (KCNA6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium voltage-gated channel subfamily A member 6 (KCNA6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call